| 1811 |
LUCIVANDE |
VANDETANIB 100 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF SYMPTOMATIC OR PROGRESSIVE MEDULLARY THYROID CANCER INPATIENT WITH UNRESECTABLE LOCALLY ADVANED OR METASTATIC DISEASE, |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1336/25 |
2025-04-21 |
2030-04-20 |
View |
| 1812 |
LUCIVANDE |
VANDETANIB 300 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF SYMPTOMATIC OR PROGRESSIVE MEDULLARY THYROID CANCER INPATIENT WITH UNRESECTABLE LOCALLY ADVANED OR METASTATIC DISEASE, |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1335/25 |
2025-04-21 |
2030-04-20 |
View |
| 1813 |
LUCIVEMU |
VEMURAFENIB 240 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENT WITH UNNRESECTABLE OR METASTATIC MELANOMA WITH BRAF V600E MUTATION. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1107/24 |
21-JUN-2024 |
20 JUN 2027 |
View |
| 1814 |
LUCIVENET |
VENETOCLAX 100 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL). |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1009/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 1815 |
LUCIVIBE |
VIBEGRON 75 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY IN ADULTS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1140/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 1816 |
LUCIVIGA |
VIGABATRIN 500 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF REFRACTORY COMPLEX PARTIAL SEIZURES AS ADJUNCTIVE THERAPY IN PATIENTS 2YEARS OF AGE AND OLDER WHO HAVE RESPONDED ANADEQUATELY TO SEVERAL ALTERNATIVE TRERATMENT |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1093/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 1817 |
LUCIVORA |
VORASIDENIB 40 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF ADULT AND PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH GRADE 2 ASTROCYTOMA OR OLIGODENDROGLIOMA WITH A SUSCEPTIBLE IDH1 OR IDH2 MUTATION FOLLOWING SURGERY INCLUDING BIOPSYM SUB-TOTAL RESECTION OR GROSS TOTAL RESECTION. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1325/25 |
28-MAR-2025 |
27-MAR-2030 |
View |
| 1818 |
LUCIVOS |
IVOSIDENIB 250 MG |
TABLET |
BOTTLE |
TREATMENT OF ACUTE MYELOID LEUKEMIA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0988/23 |
21-Jul-2023 |
20-Jul-2026 |
View |
| 1819 |
LUCIXAZ |
IXAZOMIB 4 MG |
CAPSULE |
BOTTLE |
IN COMBINATION EITH LENALIDOMIDE AND DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1026/23 |
10-OCT-2023 |
09-OCT-2026 |
View |
| 1820 |
LUCUREGOR |
REGORAFENIB 40 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER WHO HAVE BEEN PREVIOUSLY TREATED WITH FLUOROPYRIMIDINE, OXALIPLATIN AND IRINOTECAN BASED CHEMOTHERAPY, AN ANTI-VEGF THERAPY, |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1168/24 |
21-AUG-2024 |
20-AUG-2027 |
View |
